Back to top
more

Pediatrix Medical Group, Inc. (MD)

(Real Time Quote from BATS)

$8.33 USD

8.33
271,666

+0.11 (1.34%)

Updated May 13, 2024 12:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Kaibalya Pravo Dey headshot

2 Top Hospital Stocks to Buy Despite Industry Headwinds

by Kaibalya Pravo Dey

Rising supplies expense, wages and benefits, and other operating costs are lowering margins for the Zacks Medical-Hospital industry players. However, Acadia Healthcare and Pediatrix Medical are poised to win big with recovering patient volumes.

Sanghamitra Saha headshot

Ride on Rising P/E Investing With These 5 Top-Ranked Stocks

by Sanghamitra Saha

Want to try an out-of-the-box approach? Tap Oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD), Boot Barn (BOOT), Canada Goose (GOOS) and Leap Therapeutics (LPTX).

Why Pediatrix Medical (MD) is a Solid Bet for Your Portfolio

by Zacks Equity Research

Pediatrix Medical (MD) is expected to boost its services across maternal-fetal medicine, neonatology and obstetrics, plus 18 pediatric subspecialty offerings.

Will Mednax's (MD) New Name Pediatrix Medical be Beneficial?

by Zacks Equity Research

Mednax's (MD) name change is expected to take effect following the closing bell on Jul 1, 2022.

    Why Acadia Healthcare (ACHC) Dips 1.6% Despite Q1 Earnings Beat

    by Zacks Equity Research

    Acadia Healthcare (ACHC) aims to add around 300 beds to its existing facilities in 2022.

    Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes

    by Zacks Equity Research

    Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.

    Mednax (MD) Q1 Earnings and Revenues Surpass Estimates

    by Zacks Equity Research

    Mednax (MD) delivered earnings and revenue surprises of 22.22% and 1.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

    Universal Health Services (UHS) Q1 Earnings Miss Estimates

    by Zacks Equity Research

    Universal Health Services (UHS) delivered earnings and revenue surprises of -12.96% and 2.25%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

    HCA Healthcare (HCA) Q1 Earnings Miss Estimates

    by Zacks Equity Research

    HCA (HCA) delivered earnings and revenue surprises of -3.51% and 1.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

    Here's Why You Should Retain Universal Health (UHS) Stock Now

    by Zacks Equity Research

    Increased admissions at both of its operating segments, constant initiatives to bolster its care network and adequate cash generation abilities are likely to drive Universal Health (UHS).

    Acadia Healthcare (ACHC) Up 10% in 3 Months: More Room to Run?

    by Zacks Equity Research

    Solid demand for behavioral healthcare services, multiple growth-related initiatives and a solid cash balance are driving Acadia Healthcare (ACHC).

    Why Holding Humana (HUM) in Your Portfolio is a Prudent Move

    by Zacks Equity Research

    Banking on better membership and strategic initiatives, Humana (HUM) holds immense potential to reap benefits for investors.

      Sanghamitra Saha headshot

      Beyond MEME, 5 ETFs to Play Latest Reddit Craze

      by Sanghamitra Saha

      Meme stocks are those that hog attention of retail traders due to the hype surrounding them on online forums like Reddit. These stocks and ETFs could be played in order to tap the latest Reddit frenzy.

      Humana (HUM) Taps Debt Market With Senior Note Pricing

      by Zacks Equity Research

      Humana (HUM) exhibits monetary discretion by pricing senior secured notes to procure funds.

        Why Holding Centene (CNC) in Your Portfolio is a Smart Move

        by Zacks Equity Research

        Banking on a robust portfolio, buyouts and alliances plus contract wins, Centene (CNC) holds prospects to reap benefits for investors.

        Why Holding Anthem (ANTM) in Your Portfolio is a Prudent Move

        by Zacks Equity Research

        Riding high on better membership, a robust portfolio and operational excellence, Anthem (ANTM) holds potential to reap benefits for investors.

        Is it the Right Time to Add Mednax (MD) Stock to Your Kitty?

        by Zacks Equity Research

        Growing revenues, numerous acquisitions, diversified care network and adequate cash generation abilities are likely to continue driving Mednax (MD).

        HCA Healthcare (HCA) Up 43.1% in a Year: Is More Upside Left?

        by Zacks Equity Research

        Growing revenues, numerous acquisitions and a sturdy financial standing continue to drive HCA Healthcare (HCA).

        Tenet Healthcare (THC) Up 55% in a Year: Is More Upside Left?

        by Zacks Equity Research

        Growing revenues, strong performances exhibited by segments, numerous acquisitions and sturdy financial standing continue to drive Tenet Healthcare (THC).

        Anthem (ANTM) to be Renamed as Elevance Health for Rebranding

        by Zacks Equity Research

        Anthem (ANTM) intends to rename itself as Elevance Health to solidify its position in the market that goes beyond traditional insurance products.

        Should Value Investors Consider MEDNAX (MD) Stock Now?

        by Zacks Equity Research

        Is MEDNAX (MD) a great pick from the value investor's perspective right now? Read on to know more.

        Kaibalya Pravo Dey headshot

        4 Stocks to Watch From the Flourishing Hospital Industry

        by Kaibalya Pravo Dey

        Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit from improving operating efficiency.

        Here's How Mednax (MD) Can Gain By Adopting the Pediatrix Brand

        by Zacks Equity Research

        Mednax (MD) bringing some of its operations under the Pediatrix brand is expected to collectively promote its wide range of healthcare services.

        Tenet Healthcare (THC) Drops Plans to Spin Off Conifer Segment

        by Zacks Equity Research

        Tenet Healthcare (THC) aborts its Conifer spin-off plan based on its solid business opportunities and strong pipeline prospects. It also reaffirmed its 2022 guidance.

        Acadia Healthcare (ACHC) Q4 Earnings Miss on High Operating Costs

        by Zacks Equity Research

        Acadia Healthcare (ACHC) anticipates earnings per share within 62-66 cents for the March quarter of 2022.